US Stock MarketDetailed Quotes
XRTX XORTX Therapeutics
- 1.3000
- -0.1000-7.14%
Close Nov 12 16:00 ET
- 1.3008
- +0.0008+0.06%
Post 16:09 ET
4.19MMarket Cap-3513P/E (TTM)
1.4113High1.3000Low32.12KVolume1.3800Open1.4000Pre Close43.60KTurnover1.09%Turnover RatioLossP/E (Static)3.22MShares7.000052wk High1.55P/B3.84MFloat Cap1.090052wk Low--Dividend TTM2.95MShs Float55.0800Historical High--Div YieldTTM7.95%Amplitude1.0900Historical Low1.3570Avg Price1Lot Size
XORTX Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -15.21%1.49M | -42.92%1.09M | -41.25%6.05M | -63.02%983.67K | -33.75%1.39M | -33.56%1.76M | -33.68%1.91M | 253.56%10.29M | 102.94%2.66M | 562.59%2.1M |
| Selling and administrative expenses | 13.24%817.91K | 0.33%512.15K | -7.13%2.23M | -4.86%484.85K | 5.75%510.11K | -0.69%722.3K | -24.89%510.46K | 48.43%2.4M | -30.15%509.6K | 547.72%482.37K |
| -General and administrative expense | 13.24%817.91K | 0.33%512.15K | -7.13%2.23M | -4.86%484.85K | 5.75%510.11K | -0.69%722.3K | -24.89%510.46K | 48.43%2.4M | -30.15%509.6K | 547.72%482.37K |
| Research and development costs | -89.87%67.68K | -92.97%73.64K | -64.23%2.42M | -92.95%134.13K | -61.32%569.71K | -54.19%667.91K | -45.69%1.05M | 897.94%6.76M | 449.11%1.9M | 391.84%1.47M |
| Depreciation amortization depletion | 3.21%33.05K | -51.93%32.13K | 140.25%139.69K | 7.99%24.36K | -25.34%16.47K | 228.21%32.02K | 1,670.31%66.85K | 307.58%58.15K | 469.33%22.56K | 521.62%22.06K |
| -Depreciation and amortization | 3.21%33.05K | -51.93%32.13K | 140.25%139.69K | 7.99%24.36K | -25.34%16.47K | 228.21%32.02K | 1,670.31%66.85K | 307.58%58.15K | 469.33%22.56K | 521.62%22.06K |
| Other operating expenses | 69.40%575.05K | 66.30%470.7K | 17.55%1.26M | 51.59%340.34K | 135.93%297.02K | -25.63%339.47K | 6.84%283.03K | 77.87%1.07M | -2.63%224.51K | 3.07%125.9K |
| Operating profit | 15.21%-1.49M | 42.92%-1.09M | 41.25%-6.05M | 63.02%-983.67K | 33.75%-1.39M | 33.56%-1.76M | 33.68%-1.91M | -253.56%-10.29M | -102.94%-2.66M | -562.59%-2.1M |
| Net non-operating interest income expense | -50.96%35.95K | -52.69%31.6K | 144.76%253.54K | -7.26%49.82K | 79.40%63.61K | 523.19%73.31K | 2,421.78%66.8K | 2,427.32%103.59K | 4,018.84%53.72K | 3,372.81%35.46K |
| Non-operating interest income | -50.96%35.95K | -52.69%31.6K | ---- | ---- | 79.40%63.61K | 523.19%73.31K | 2,421.78%66.8K | ---- | ---- | --35.46K |
| Total other finance cost | ---- | ---- | -144.76%-253.54K | ---- | ---- | ---- | ---- | -2,427.32%-103.59K | ---- | ---- |
| Other net income (expense) | 46,688.55%1.63M | -23,298.79%-1.96M | 47.25%3.63M | 13,367.34%3.63M | -100.42%-3.67K | -100.25%-3.49K | -95.01%8.46K | 84.77%2.47M | -99.67%26.98K | 113.97%870.55K |
| Gain on sale of security | 46,688.55%1.63M | -23,298.79%-1.96M | 7.06%3.63M | 281.05%3.63M | -100.42%-3.67K | -100.25%-3.49K | -95.01%8.46K | 29.37%3.39M | -89.91%953.43K | 113.97%870.55K |
| Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 28.08%-926.46K | ---- | ---- |
| -Less：Restructuring and merger&acquisition | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -28.08%926.46K | ---- | ---- |
| Income before tax | 110.05%170.07K | -64.79%-3.02M | 72.04%-2.16M | 204.65%2.7M | -11.38%-1.33M | -36.57%-1.69M | 32.24%-1.83M | -388.76%-7.72M | -137.68%-2.58M | 81.72%-1.2M |
| Income tax | ||||||||||
| Net income | 110.05%170.07K | -64.79%-3.02M | 72.04%-2.16M | 204.65%2.7M | -11.38%-1.33M | -36.57%-1.69M | 32.24%-1.83M | -388.76%-7.72M | -137.68%-2.58M | 81.72%-1.2M |
| Net income continuous Operations | 110.05%170.07K | -64.79%-3.02M | 72.04%-2.16M | 204.65%2.7M | -11.38%-1.33M | -36.57%-1.69M | 32.24%-1.83M | -388.76%-7.72M | -137.68%-2.58M | 81.72%-1.2M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 110.05%170.07K | -64.79%-3.02M | 72.04%-2.16M | 204.65%2.7M | -11.38%-1.33M | -36.57%-1.69M | 32.24%-1.83M | -388.76%-7.72M | -137.68%-2.58M | 81.72%-1.2M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 110.05%170.07K | -64.79%-3.02M | 72.04%-2.16M | 204.65%2.7M | -11.38%-1.33M | -36.57%-1.69M | 32.24%-1.83M | -388.76%-7.72M | -137.68%-2.58M | 81.72%-1.2M |
| Basic earnings per share | 107.06%0.06 | -30.53%-1.24 | 79.12%-1.09 | 181.90%1.3598 | 19.28%-0.6699 | -4.94%-0.85 | 49.74%-0.95 | -262.50%-5.22 | -123.87%-1.6604 | 86.78%-0.8299 |
| Diluted earnings per share | 107.06%0.06 | -30.53%-1.24 | 79.12%-1.09 | 181.90%1.3598 | 19.28%-0.6699 | -4.94%-0.85 | 49.74%-0.95 | -262.50%-5.22 | -123.87%-1.6604 | 86.78%-0.8299 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data